Page last updated: 2024-10-26

etodolac and Fetal Membranes, Premature Rupture

etodolac has been researched along with Fetal Membranes, Premature Rupture in 1 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Fetal Membranes, Premature Rupture: Spontaneous tearing of the membranes surrounding the FETUS any time before the onset of OBSTETRIC LABOR. Preterm PROM is membrane rupture before 37 weeks of GESTATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Janzen, C1
Sen, S1
Lei, MY1
Gagliardi de Assumpcao, M1
Challis, J1
Chaudhuri, G1

Other Studies

1 other study available for etodolac and Fetal Membranes, Premature Rupture

ArticleYear
The Role of Epithelial to Mesenchymal Transition in Human Amniotic Membrane Rupture.
    The Journal of clinical endocrinology and metabolism, 2017, 04-01, Volume: 102, Issue:4

    Topics: Amnion; Cyclooxygenase 2 Inhibitors; Epithelial-Mesenchymal Transition; Etodolac; Female; Fetal Memb

2017